CXCR4 and acute myeloid leukemia: In a prospective study, patients with AML were divided into groups with low, intermediate or high levels of CXCR4 expression, as determined by CXCR4 mean fluorescence intensity ratio thresholds of <5, 5‐10 and ≥10, respectively, which resulted in significantly different outcomes.50